vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Five9, Inc. (FIVN). Click either name above to swap in a different company.
Five9, Inc. is the larger business by last-quarter revenue ($300.3M vs $236.8M, roughly 1.3× CROSS COUNTRY HEALTHCARE INC). On growth, Five9, Inc. posted the faster year-over-year revenue change (7.8% vs -23.6%). Five9, Inc. produced more free cash flow last quarter ($77.3M vs $16.1M). Over the past eight quarters, Five9, Inc.'s revenue compounded faster (10.3% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Five9, Inc. is a leading global provider of cloud-native contact center software and solutions. It serves enterprises of all sizes across retail, healthcare, financial services, and technology sectors, offering omnichannel customer engagement tools, AI-powered automation, workforce management, and analytics to boost customer experience and operational efficiency.
CCRN vs FIVN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $300.3M |
| Net Profit | $-82.9M | — |
| Gross Margin | — | 55.4% |
| Operating Margin | -30.2% | 6.6% |
| Net Margin | -35.0% | — |
| Revenue YoY | -23.6% | 7.8% |
| Net Profit YoY | -2109.7% | — |
| EPS (diluted) | $-2.56 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $300.3M | ||
| Q3 25 | $250.1M | $285.8M | ||
| Q2 25 | $274.1M | $283.3M | ||
| Q1 25 | $293.4M | $279.7M | ||
| Q4 24 | $309.9M | $278.7M | ||
| Q3 24 | $315.1M | $264.2M | ||
| Q2 24 | $339.8M | $252.1M | ||
| Q1 24 | $379.2M | $247.0M |
| Q4 25 | $-82.9M | — | ||
| Q3 25 | $-4.8M | $18.0M | ||
| Q2 25 | $-6.7M | $1.2M | ||
| Q1 25 | $-490.0K | $576.0K | ||
| Q4 24 | $-3.8M | — | ||
| Q3 24 | $2.6M | $-4.5M | ||
| Q2 24 | $-16.1M | $-12.8M | ||
| Q1 24 | $2.7M | $-7.1M |
| Q4 25 | — | 55.4% | ||
| Q3 25 | 20.4% | 55.0% | ||
| Q2 25 | 20.4% | 54.9% | ||
| Q1 25 | 20.0% | 55.0% | ||
| Q4 24 | — | 56.0% | ||
| Q3 24 | 20.4% | 53.8% | ||
| Q2 24 | 20.8% | 53.0% | ||
| Q1 24 | 20.4% | 53.6% |
| Q4 25 | -30.2% | 6.6% | ||
| Q3 25 | -2.4% | 5.6% | ||
| Q2 25 | -2.1% | -0.6% | ||
| Q1 25 | -0.3% | -1.9% | ||
| Q4 24 | -1.1% | 1.5% | ||
| Q3 24 | 0.9% | -5.8% | ||
| Q2 24 | -5.7% | -7.7% | ||
| Q1 24 | 0.8% | -8.4% |
| Q4 25 | -35.0% | — | ||
| Q3 25 | -1.9% | 6.3% | ||
| Q2 25 | -2.4% | 0.4% | ||
| Q1 25 | -0.2% | 0.2% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 0.8% | -1.7% | ||
| Q2 24 | -4.7% | -5.1% | ||
| Q1 24 | 0.7% | -2.9% |
| Q4 25 | $-2.56 | $0.22 | ||
| Q3 25 | $-0.15 | $0.21 | ||
| Q2 25 | $-0.20 | $0.01 | ||
| Q1 25 | $-0.02 | $0.01 | ||
| Q4 24 | $-0.13 | $0.16 | ||
| Q3 24 | $0.08 | $-0.06 | ||
| Q2 24 | $-0.47 | $-0.17 | ||
| Q1 24 | $0.08 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $232.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $785.8M |
| Total Assets | $449.0M | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $232.1M | ||
| Q3 25 | $99.1M | $193.4M | ||
| Q2 25 | $81.2M | $205.5M | ||
| Q1 25 | $80.7M | $370.3M | ||
| Q4 24 | $81.6M | $362.5M | ||
| Q3 24 | $64.0M | $291.0M | ||
| Q2 24 | $69.6M | $175.7M | ||
| Q1 24 | $5.2M | $240.2M |
| Q4 25 | $322.8M | $785.8M | ||
| Q3 25 | $408.1M | $775.3M | ||
| Q2 25 | $412.2M | $717.4M | ||
| Q1 25 | $418.2M | $664.3M | ||
| Q4 24 | $419.0M | $622.2M | ||
| Q3 24 | $424.7M | $565.6M | ||
| Q2 24 | $433.3M | $525.9M | ||
| Q1 24 | $462.4M | $483.6M |
| Q4 25 | $449.0M | $1.8B | ||
| Q3 25 | $538.2M | $1.8B | ||
| Q2 25 | $553.8M | $1.7B | ||
| Q1 25 | $576.2M | $2.1B | ||
| Q4 24 | $589.3M | $2.1B | ||
| Q3 24 | $597.4M | $2.0B | ||
| Q2 24 | $602.9M | $1.9B | ||
| Q1 24 | $648.4M | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $83.6M |
| Free Cash FlowOCF − Capex | $16.1M | $77.3M |
| FCF MarginFCF / Revenue | 6.8% | 25.8% |
| Capex IntensityCapex / Revenue | 0.9% | 2.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $201.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $83.6M | ||
| Q3 25 | $20.1M | $59.2M | ||
| Q2 25 | $4.2M | $35.1M | ||
| Q1 25 | $5.7M | $48.4M | ||
| Q4 24 | $24.2M | $49.8M | ||
| Q3 24 | $7.5M | $41.1M | ||
| Q2 24 | $82.4M | $19.9M | ||
| Q1 24 | $6.0M | $32.4M |
| Q4 25 | $16.1M | $77.3M | ||
| Q3 25 | $17.9M | $48.7M | ||
| Q2 25 | $2.3M | $31.6M | ||
| Q1 25 | $3.8M | $43.7M | ||
| Q4 24 | $21.7M | $40.5M | ||
| Q3 24 | $6.3M | $26.7M | ||
| Q2 24 | $79.6M | $13.1M | ||
| Q1 24 | $3.8M | $20.4M |
| Q4 25 | 6.8% | 25.8% | ||
| Q3 25 | 7.2% | 17.0% | ||
| Q2 25 | 0.8% | 11.1% | ||
| Q1 25 | 1.3% | 15.6% | ||
| Q4 24 | 7.0% | 14.5% | ||
| Q3 24 | 2.0% | 10.1% | ||
| Q2 24 | 23.4% | 5.2% | ||
| Q1 24 | 1.0% | 8.3% |
| Q4 25 | 0.9% | 2.1% | ||
| Q3 25 | 0.9% | 3.7% | ||
| Q2 25 | 0.7% | 1.2% | ||
| Q1 25 | 0.6% | 1.7% | ||
| Q4 24 | 0.8% | 3.3% | ||
| Q3 24 | 0.4% | 5.4% | ||
| Q2 24 | 0.8% | 2.7% | ||
| Q1 24 | 0.6% | 4.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.29× | ||
| Q2 25 | — | 30.38× | ||
| Q1 25 | — | 84.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
FIVN
Segment breakdown not available.
